Linked Life Data

20483025

Source:http://linkedlifedata.com/resource/pubmed/id/20483025

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-10-20
pubmed:abstractText
The present article presents an overview of the literature, and analyses the methods and the primary questions related to assessment of proliferation index using the Ki-67/MIB-1 labeling index in pituitary adenomas. Although atypical adenomas are characterized by their atypical morphological features by an elevated mitotic index, a Ki-67 (MIB-1) labeling index greater than 3% and extensive nuclear staining for p53, use of the proliferation index (LI) of pituitary adenomas in assessing the degree of tumor aggressiveness is a controversial topic in the literature, and there are disparate results involving many studies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1743-1328
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1060-71
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
pubmed:affiliation
Department of Neurology, São Paulo Medical School, State University of São Paulo, Brazil. phpaneurocir@gmail.com
pubmed:publicationType
Journal Article, Review